Tab. 3: Chemicals tested for CYP26A1 and/or CYP26B1 inhibition in selected publications.
Thatcher et al., 2011 | Foti et al., 2016a | Foti et al., 2016b | Buttrick, 2013 | ||||
---|---|---|---|---|---|---|---|
Chemical | CYP26A1 | CYP26A1 | CYP26B1 | CYP26A1 | CYP26B1 | CYP26A1 | CYP26B1 |
17-alpha-ethinyl estradiol | X | X | |||||
AM580 | X | X | X | X | |||
AM80 (tamibarotene) | X | X | X | X | X | X | |
Benzbromarone | X | X | |||||
Bexarotene | X | X | X | X | |||
BMS753 | X | X | X | X | |||
BMS961 | X | X | X | X | |||
Candesartan | X | X | |||||
Candesartan cilexetil | X | X | |||||
CD1530 | X | ||||||
CD437 | X | X | |||||
Clotrimazole | X | X | |||||
CS5 | X | ||||||
EC23 | X | X | X | X | |||
Fluconazole | X | X | |||||
Itraconazole | X | X | |||||
Ketoconazole | X | X | X | X | X | ||
L-165,041 | X | ||||||
Liarozole | X | X | X | X | X | ||
MM11253 | X | X | X | X | |||
Mometasone | X | X | |||||
Montelukast | X | X | |||||
Pioglitazone | X | X | X | ||||
Quercetin | X | X | |||||
R115866 (talarozole) | X | X | X | X | X | ||
R116010 | X | X | X | ||||
Raloxifene | X | X | |||||
Repaglinide | X | X | |||||
Ritonavir | X | X | |||||
Rosiglitazone | X | X | X | ||||
SR11237 | X | X | X | X | |||
Tamoxifen | X | X | |||||
Tazarotene | X | X | |||||
Tazarotenic acid (Agn 190299) | X | X | X | X | |||
TTNPB | X | X | X | X | X | ||
Zafirlukast | X | X |